C. Shannon-Weickert

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

R. Gibbs, R. Straub, M. Egan, 2004, Proceedings of the National Academy of Sciences of the United States of America.

BIOMARKERS

C. Shannon-Weickert, 2014, Schizophrenia Research.

Does synaptic pathology in schizophrenia involve a selective dendritic spine deficit? A study of spinophilin and MAP2 gene expression in the hippocampus

Paul J. Harrison, J. Kleinman, T. Hyde, 2003, Schizophrenia Research.